Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 13, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$9.24B
sum of reported positions
Reported positions
122
Changes vs prior quarter
113
23 new · 8 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 264 measured positions in 8 quarters, the typical new or larger position finished −1.0 pts against the S&P 500 and 47% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 9.36M | $1.75B | 19.0% | |
| 41.2M | $1.18B | 12.7% | |
| 29.4M | $994M | 10.8% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $8.15B | $9.24B |
| Positions | 107 | 122 |
| Biggest line | — | Astrazeneca 19% |
| 15M |
| $696M |
| 7.5% |
| 6.71M | $582M | 6.3% |
| 532K | $254M | 2.8% |
| 3.18M | $166M | 1.8% |
| 2.18M | $160M | 1.7% |
| 706K | $129M | 1.4% |
| 955K | $123M | 1.3% |
| 201K | $113M | 1.2% |
| 316K | $112M | 1.2% |
| 3.98M | $107M | 1.2% |
| 255K | $99.5M | 1.1% |
| 630K | $97.1M | 1.1% |
| 995K | $95.5M | 1.0% |
| 860K | $92.4M | 1.0% |
| 253K | $90.3M | 1.0% |
| 1.03M | $84.8M | 0.9% |
| 3.06M | $83.3M | 0.9% |
| 1.68M | $80.4M | 0.9% |
| 248K | $76.9M | 0.8% |
| 1.08M | $75.5M | 0.8% |
| 572K | $73.3M | 0.8% |
| 899K | $72.3M | 0.8% |
Smurfit Westrock (SW)
15.6M → 15M shares (−3%)
Canadian Pacific Kansas City Ltd (CP)
8.79M → 6.71M shares (−24%)
Alphabet (GOOGL)
337K → 316K shares (−6%)
Barclays (BCS)
4.07M → 3.98M shares (−2%)
Alibaba Group Holding (BABA)
1.07M → 995K shares (−7%)
Zimmer Biomet (ZBH)
808K → 789K shares (−2%)
Citigroup (C)
635K → 459K shares (−28%)
Analog Devices (ADI)
202K → 142K shares (−30%)
Relx (RELX)
2.31M → 1.76M shares (−24%)
Anglogold Ashanti (AU)
899K → 688K shares (−24%)
Texas Instruments (TXN)
206K → 166K shares (−19%)
Disney (DIS)
560K → 361K shares (−36%)
Sanofi (SNY)
1.06M → 804K shares (−25%)
VANGUARD FTSE DEVELOPED MARKETS ETF
737K → 427K shares (−42%)
Anheuser-Busch Inbev (BUD)
580K → 348K shares (−40%)
Pagseguro Digital (PAGS)
4.04M → 3.13M shares (−23%)
Genpact (G)
1.95M → 710K shares (−64%)
Cognizant (CTSH)
1.5M → 495K shares (−67%)
Zim Integrated Shipping Services (ZIM)
890K → 694K shares (−22%)
Weibo (WB)
2.67M → 2.32M shares (−13%)
VANGUARD FTSE ALL WORLD EX-US SMALL-CAP ETF
104K → 81K shares (−22%)
Finvolution Group (FINV)
2.4M → 2.29M shares (−5%)
Joyy (JOYY)
751K → 109K shares (−85%)
Celestica (CLS)
25K → 20K shares (−21%)
Millicom International Cellular (TIGO)
209K → 66K shares (−68%)
